This issue of Endocrinology and Metabolism Clinics, guest edited by Dr. Michael Mingzhao Xing, is dedicated to Thyroid Cancer. Topics include, but are not limited to, Current Histological Classification of Thyroid Cancer, Molecular Pathogenesis and Mechanisms of Thyroid Cancer, Clinical Diagnostic Evaluation of Thyroid Nodules, Molecular Diagnostic Evaluation of Thyroid Nodules, Clinical Risk Stratification of Differentiated Thyroid Cancer, Molecular Risk Stratification of Differentiated Thyroid Cancer, Conventional Thyroidectomy in the Treatment of Primary Thyroid Cancer, Neck Dissection in the Surgical Treatment of Thyroid Cancer, Conventional Robotic Endoscopic Thyroidectomy for Thyroid Cancer, Transoral Endoscopic Thyroidectomy for Thyroid Cancer, Conventional Radioiodine Therapy for Differentiated Thyroid Cancer, Re-differentiation of Radioiodine-refractory Thyroid Cancer for Radioiodine Treatment, Management of Papillary Thyroid Microcarcinoma, Conservative Surveillance Management of Low-risk Papillary Thyroid Microcarcinoma, Thyroid-stimulating Hormone Suppression Therapy in Differentiated Thyroid Cancer, Diagnostic Imaging Testing in the Surveillance of Thyroid Cancer Recurrence, Novel Drug Treatments of Progressive Radioiodine-refractory Differentiated Thyroid Cancer, Management of Anaplastic Thyroid Cancer, and Management of Medullary Thyroid cancer.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xiii 7. Foreword - p. xv 8. Preface - p. xvii 9. The Current Histologic Classification of Thyroid Cancer - p. 1 10. Evolving Understanding of the Epidemiology of Thyroid Cancer - p. 23 11. Coding Molecular Determinants of Thyroid Cancer Development and Progression - p. 37 12. Clinical Diagnostic Evaluation of Thyroid Nodules - p. 61 13. Molecular Diagnostic Evaluation of Thyroid Nodules - p. 85 14. Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer - p. 99 15. Genetic-guided Risk Assessment and Management of Thyroid Cancer - p. 109 16. Conventional Thyroidectomy in the Treatment of Primary Thyroid Cancer - p. 125 17. Neck Dissection in the Surgical Treatment of Thyroid Cancer - p. 143 18. Conventional Robotic Endoscopic Thyroidectomy for Thyroid Cancer - p. 153 19. Transoral Endoscopic Thyroidectomy for Thyroid Cancer - p. 165 20. Conventional Radioiodine Therapy for Differentiated Thyroid Cancer - p. 181 21. Management of Papillary Thyroid Microcarcinoma - p. 199 22. Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma - p. 215 23. Thyroid Hormone Suppression Therapy - p. 227 24. Surveillance for Differentiated Thyroid Cancer Recurrence - p. 239 25. Novel Drug Treatments of Progressive Radioiodine-Refractory Differentiated Thyroid Cancer - p. 253 26. Diagnosis and Management of Anaplastic Thyroid Cancer - p. 269 27. Management of Medullary Thyroid Cancer - p. 285
No hay muestra disponible
No hay ficha técnica disponible
This issue of Endocrinology and Metabolism Clinics, guest edited by Dr. Michael Mingzhao Xing, is dedicated to Thyroid Cancer. Topics include, but are not limited to, Current Histological Classification of Thyroid Cancer, Molecular Pathogenesis and Mechanisms of Thyroid Cancer, Clinical Diagnostic Evaluation of Thyroid Nodules, Molecular Diagnostic Evaluation of Thyroid Nodules, Clinical Risk Stratification of Differentiated Thyroid Cancer, Molecular Risk Stratification of Differentiated Thyroid Cancer, Conventional Thyroidectomy in the Treatment of Primary Thyroid Cancer, Neck Dissection in the Surgical Treatment of Thyroid Cancer, Conventional Robotic Endoscopic Thyroidectomy for Thyroid Cancer, Transoral Endoscopic Thyroidectomy for Thyroid Cancer, Conventional Radioiodine Therapy for Differentiated Thyroid Cancer, Re-differentiation of Radioiodine-refractory Thyroid Cancer for Radioiodine Treatment, Management of Papillary Thyroid Microcarcinoma, Conservative Surveillance Management of Low-risk Papillary Thyroid Microcarcinoma, Thyroid-stimulating Hormone Suppression Therapy in Differentiated Thyroid Cancer, Diagnostic Imaging Testing in the Surveillance of Thyroid Cancer Recurrence, Novel Drug Treatments of Progressive Radioiodine-refractory Differentiated Thyroid Cancer, Management of Anaplastic Thyroid Cancer, and Management of Medullary Thyroid cancer.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xiii 7. Foreword - p. xv 8. Preface - p. xvii 9. The Current Histologic Classification of Thyroid Cancer - p. 1 10. Evolving Understanding of the Epidemiology of Thyroid Cancer - p. 23 11. Coding Molecular Determinants of Thyroid Cancer Development and Progression - p. 37 12. Clinical Diagnostic Evaluation of Thyroid Nodules - p. 61 13. Molecular Diagnostic Evaluation of Thyroid Nodules - p. 85 14. Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer - p. 99 15. Genetic-guided Risk Assessment and Management of Thyroid Cancer - p. 109 16. Conventional Thyroidectomy in the Treatment of Primary Thyroid Cancer - p. 125 17. Neck Dissection in the Surgical Treatment of Thyroid Cancer - p. 143 18. Conventional Robotic Endoscopic Thyroidectomy for Thyroid Cancer - p. 153 19. Transoral Endoscopic Thyroidectomy for Thyroid Cancer - p. 165 20. Conventional Radioiodine Therapy for Differentiated Thyroid Cancer - p. 181 21. Management of Papillary Thyroid Microcarcinoma - p. 199 22. Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma - p. 215 23. Thyroid Hormone Suppression Therapy - p. 227 24. Surveillance for Differentiated Thyroid Cancer Recurrence - p. 239 25. Novel Drug Treatments of Progressive Radioiodine-Refractory Differentiated Thyroid Cancer - p. 253 26. Diagnosis and Management of Anaplastic Thyroid Cancer - p. 269 27. Management of Medullary Thyroid Cancer - p. 285
No hay muestra disponible
No hay ficha técnica disponible
